Pharmacological treatment of hypercholesterolaemia in primary prevention. The use of the different sources of information;Traitement pharmacologique de l'hypercholestérolémie en prévention primaire: L'exploitation des sources d'information

Revue Medicale de Liege

Volumn 60, Issue 9, 2005, Pages 711-718

  Van Den Bruel, A ^a,b   Gobert, M ^a,c   Vermeire, E ^a,d   Buntinx, F ^b   Aertgeerts, B ^a,b  

^a Belgian Center for Evidence Based Medicine   (Belgium)

^b Katholieke Universitieit van Leuven (KUL)   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Database; Evidence based medicine; Hypercholesterolaemia; Statin

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; MEDICAL INFORMATION; MORTALITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; TREATMENT PLANNING; ADULT; CORONARY ARTERY DISEASE; FEMALE; REVIEW;

ADULT; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; PRIMARY PREVENTION;

EID: 26444589088     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Van den Bruel A, Boland B, Vermeire E, et al.-Du PICO aux termes de recherche par Internet: comment accéder à l'information pertinente? Rev Med Liège, 2005, 60, 52-60.
2. Van den Bruel A, Buntinx F, Aertgeerts B.-Evidence-Based Medicine: plus qu'un terme à la mode. Rev Med Liège, 2004, 59, 669-670.
3. Van den Bruel A, Chevalier P, Vermeire E, et al.-Evidence-Based Medicine. Otite moyenne chez l'enfant. Comment formuler une question PICO? Rev Med Liège, 2004, 59, 671-675.
4. SSMG.-Recommandations de bonne pratique SSMG. Hypercholesté rolémie. SSMG, 2001, 90 p. + annexes
5. Scottish Intercollegiate Guidelines Network.-Lipids and the Primary Prevention of Coronary Heart Disease. A National Clinical Guideline. SIGN, 1999, publication number 10.
6. Veterans Health Administration, Department of Defense.-VHA/DoD clinical practice guideline for the management of dyslipidemia in primary care. Washington (DC): Veterans Health Administration, Department of Defense, 2001.
7. Ann Arbor (MI): University of Michigan.-Screening and management of lipids, 2000.
8. Singapore Ministry of Health.-Lipids. Singapore: Singapore Ministry of Health, 2001.
9. Institute for Clinical Systems Improvement (ICSI).-Lipid management in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI), 2002 Jul.
10. American Association of Clinical Endocrinologists.-AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract, 2000, 6, 162-213.
11. Wood D, De Backer C, Faergeman O, et al.-Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis, 1998, 140, 199-270.
12. Van Driel M, Lemiengre M, Christiaens T.-Hypercholesterolemie: state of the art anno 2002. Huisarts Nu (Minerva), 2002, 31, 101-4.
13. Christiaens T-De aanpak van primaire hypercholesterolemie anno 2002. Huisarts Nu (Minerva), 2002, 31, 87-94.
14. Thomas S.-Primaire preventie met statines: heeft het zin? Huisarts Nu (Minerva), 1999, 28, 379-82.
15. Pignone M.-Primary prevention - What are the effects of lowering cholesterol concentration in asymptomatic people. Cardiovascular disorders, BMJ Clinical Evidence 2003.
16. Havraneck EP.-Review: Lipid-lowering drugs decrease CAD events but not all-cause or CAD mortality in men with no history of CAD. ACP Journal Club, 2001, 134, 92.
17. Gluckman R.-Review: Multiple interventions modestly reduce cardiovascular risk factors in primary prevention, but effects on mortality are uncertain. ACP Journal Club, 2000, 132, 43.
18. Taylor WC, Berkenblit A.-Lovastatin reduced coronary events in healthy persons with low HDL cholesterol levels. ACP Journal Club, 1998, 129, 58.
19. Spence JD.-Meta-analysis: antidyslipidemic therapy prevents myocardial infarction and death. ACP Journal Club, 1997, 126, 4.
20. Taylor WC.-Review: Cholesterol lowering reduces mortality in high-risk, middle-aged men. ACP Journal Club, 1996, 125, 13.
21. Ebrahim S, Davey Smith G.-Multiple risk factor interventions for primary prevention of coronary heart disease. The Cochrane Library, 2002, Issue 4.
22. Center for Reviews and Dissemination.-What role for statins: a review and economic model. Database of Abstracts of Reviews of Effectiveness, 2002, Volume 4.
23. Center for Reviews and Dissemination.-Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. Database of Abstracts of Reviews of Effectiveness, 2002; Volume 4.
24. Center for Reviews and Dissemination.-Reductase inhibitor monotherpay and stroke prevention. Database of Abstracts of Reviews of Effectiveness, 2002; Volume 4.
25. Center for Reviews and Dissemination.-Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy. Database of Abstracts of Reviews of Effectiveness, 2002; Volume 4.